Lonza
Lonza and Engitix partner to develop next-generation antibody-drug conjugates
July 28, 2026Engitix, Lonza, antibody-drug conjugates
Lonza and Engitix have entered into a licensing agreement to support the development of antibody-drug conjugates (ADCs), combining Engitix’s extracellular …
Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn
March 20, 2024Manufacturing and Production Lonza, Pharmacy, Roche, biologics, facility, manufacturing
Lonza has announced that it has signed an agreement to acquire the Genentech large-scale biologics site based in Vacaville, California, …
Lonza to acquire Synaffix to strengthen ADC development
June 1, 2023Medical Communications ADC, Lonza, Oncology, Synaffix, drug development
Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has acquired Synaffix, a biotech company …
Moderna submits BLA with FDA for COVID vaccine
June 2, 2021Research and Development COVID-19, EU, FDA, Lonza, Moderna, production
Moderna has initiated the rolling submission process with the FDA for a Biologics License Application (BLA) for the licensure of …
Lonza to invest over £150 million on new molecule complex
April 23, 2021Medical Communications Lonza
Lonza have announced the construction of a new small molecule manufacturing complex at its Visp site in Switzerland, which will …
Altimmune expands COVID-19 vaccine manufacturing deal with Lonza
March 12, 2021Medical Communications Altimmune, COVID-19, Lonza, vaccines
Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …
Lonza CEO to step down in 2020
November 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, appointment
It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to step down from the role …
Richard Ridinger resigns from CEO position at Lonza causing shares to plummet
January 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland
Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
Lonza cleared to acquire Capsugel in $5.5 billion deal
June 28, 2017Manufacturing and Production, Research and Development, Sales and Marketing Capsugel, Lonza, acquisition
Swiss pharmaceutical manufacturer Lonza has announced that it has been cleared to proceed with its $5.5 billion acquisition of New …
Sanofi and Lonza partner up for €270m biologics facility
February 28, 2017Manufacturing and Production Lonza, Sanofi
Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …
Lonza in $5.5 billion deal to acquire Capsugel
December 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion
Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …
Lonza grows manufacturing capability by opening further site
November 4, 2016Medical Communications Lonza, drug product services, manufacturing
Lonza, a Swiss multinational chemical and biotechnology company, has opened a new manufacturing facility in Basel, where their headquarters is …
TiGenix and Lonza partner on stem cell manufacturing
February 13, 2015Manufacturing and Production, Sales and Marketing Crohn’s disease, Lonza, Stem cells, TiGenix, crohn's disease, eascs, manufacturing, spa
Stem cell therapy developer TiGenix has enlisted the help of biologics manufacturer Lonza to produce its medicine Cx601 for late-stage …
BMS and Lonza announce expansion plans
October 31, 2014Manufacturing and Production, Sales and Marketing BMS, Lonza, Orencia, manufacturing, opdivo
Bristol-Myers Squibb (BMS) and Lonza are to expand upon an existing manufacturing agreement to meet anticipated demand for commercial biologics. …
Lonza adds executive committee member
June 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, sven Abend
Sven Abend is joining Swiss chemicals and biotech giant Lonza to serve on its executive committee. From July Abend will …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
